A leading Indian pharmaceutical company has launched a polio vaccine, POLPROTEC in Nigeria to help combat the spread of polio in Africa's top oil producer.
To make the vaccine easily available, Panacea Biotec is partnering Emzor pharma which has a strong footprint across Nigeria. The country is still facing the challenge of polio virus.
To make the vaccine easily available, Panacea Biotec is partnering Emzor pharma which has a strong footprint across Nigeria. The country is still facing the challenge of polio virus.
During the launch, Panacea and Emzor made a public declaration of a
Joint Polio-Free Mission "To contribute towards achieving the goal of
global polio eradication and to ensure that no child will ever again be
paralyzed by WPV or Vaccine-Derived Polio Virus (VDPV)."
This would be achieved by providing complete portfolio of Oral Polio Vaccines (OPV), Inactivated Polio Vaccine (IPV) and IPV based combination vaccine at an affordable price.
The two firms noted that this is the first time IPV is launched in Nigeria and that India has slowly moved out of PAIN (Pakistan, Afghanistan, India and Nigeria), referred to as the only 4 Polio endemic countries in the world.
This would be achieved by providing complete portfolio of Oral Polio Vaccines (OPV), Inactivated Polio Vaccine (IPV) and IPV based combination vaccine at an affordable price.
The two firms noted that this is the first time IPV is launched in Nigeria and that India has slowly moved out of PAIN (Pakistan, Afghanistan, India and Nigeria), referred to as the only 4 Polio endemic countries in the world.
No comments:
Post a Comment